Inbox: Mass Cannabis Regulators Issue Statements Relative To Federal Rescheduling
December 18, 2025
“This change has the potential to expand access to evidence-based therapies while maintaining strong safeguards”
“This change has the potential to expand access to evidence-based therapies while maintaining strong safeguards”
Neither the president nor his spokespersons have provided any further updates regarding either their intentions or their timeline
Answers about Trump’s potential reclassification of marijuana including what could happen to current state programs
According to some lawmakers, the POTUS “has the opportunity to further reduce the harms of marijuana’s criminalization”
The Department of Health and Human Services recommended marijuana be moved to Schedule III last August and the Justice Department published a proposed rule to change cannabis’ classification in May. Here’s what’s next …
“The scientific evidence in favor of removing cannabis from Schedule I remains overwhelming.”
State cannabis advisors pass recommendations on rescheduling, island access, and vertical integration
The federal comment portal is still open for nearly two months—here’s how you can submit comments on cannabis reclassification
Cannabis is about to be ‘re-scheduled’ by feds. What does that mean for Florida Amendment 3?
There are few published clinical trials of psilocybin therapy for chronic pain, although many are ongoing, including a pilot study for fibromyalgia
